Cone Beam vs MDCT for Diagnosis and Pre-operative Evaluation of Otosclerosis (CONBEAM OTO)

October 20, 2022 updated by: University Hospital, Bordeaux
This study aims to compare the Cone Beam and the multi-detector computed tomography for diagnosis and pre-operative evaluation of otosclerosis in patients addressed for conductive hearing loss with intact tympanic membrane. The study aims to show that the Cone Beam offers equivalent performances with lower radiation dosage in this indication

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

Otosclerosis is an inflammatory bone remodeling disorder of the otic capsule, characterized by spongiotic new bone formation, causing stamped ankylosis that can result in conductive hearing loss. Until now, the gold standard imaging technique for diagnosis and pre-operative evaluation of otosclerosis has been multi-detector computed tomography (MDCT). Cone Beam computed tomography is a relatively recent imaging modality. It is associated with a lower radiation dosage compared to MDCT, and a high spatial resolution that allows a more precise analysis of bone structures. During the last 15 years, its use has been increasingly common in odontology and craniofacial surgery. Several studies have already studied the utility of Cone Beam for temporal bone pathologies, including recent retrospective studies that showed satisfying diagnostic performances for otosclerosis. Up to now, very few prospective studies have compared those two imaging modalities for otosclerosis diagnosis and pre-operative evaluation.

Therefore, those two exams will be performed in patients addressed to the hospital for conductive hearing loss with intact tympanic membrane. Thus, the performance of Cone Beam will be compared to MDCT, regarding the positive diagnosis of otosclerosis, the analysis of anatomical structures of the temporal bone for pre-operative evaluation, and also the benefits in terms of irradiation. The MDCTs will include fewer slices than routine MDCTs and will be centered on the area of interest, in order to keep a total radiation dosage smaller or equivalent to routine care

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bordeaux, France
        • CHU de Bordeaux

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adult patients (18 years and older)
  • Requiring radiological assessment for conductive hearing loss with intact tympanic membrane, confirmed by otoscopy and audiogram
  • Signed informed consent
  • Affiliated or beneficiary of health insurance

Exclusion Criteria:

  • Absence of otosclerosis on the MDCT
  • History of middle ear surgery
  • Pregnancy, breast feeding women and women who are of childbearing age and not practicing adequate birth control
  • Patient under legal protection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Cone Beam CT
Each patient will undergo a Cone Beam CT and a MDCT
Each patient will undergo a Cone Beam CT and a MDCT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
False negative rate of Cone Beam for the diagnosis of otosclerosis
Time Frame: 1 day
False negative rate of Cone Beam for the diagnosis of otosclerosis, compared to MDCT (gold standard).
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
radiologic grades of otosclerosis
Time Frame: 1 day
Description of the radiologic grades of otosclerosis, based on Veillon's classification
1 day
extension to round window
Time Frame: 1 day

The parameter that will be assessed is the presence/absence of a bony hypodensity located on the round window bony structure .

CT will be considered as gold standard. CBCT may be less or equally accurate to detect this small hypodensity area structure

1 day
Existence of a bone canal around the labyrinthine portion of the facial nerve
Time Frame: 1 day

The parameter that will be assessed is the presence /absence of a bony structure covering the VIIth nerve a the level of the oval window.

CT will be considered as gold standard. CBCT may be less or equally accurate to detect this very thin bony structure , or even better in case of better detection

1 day
radiation dosage
Time Frame: 1 day
Comparison of radiation dosage between Cone Beam and MDCT
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 18, 2022

Primary Completion (ACTUAL)

August 1, 2022

Study Completion (ACTUAL)

August 1, 2022

Study Registration Dates

First Submitted

December 1, 2021

First Submitted That Met QC Criteria

January 27, 2022

First Posted (ACTUAL)

January 28, 2022

Study Record Updates

Last Update Posted (ACTUAL)

October 24, 2022

Last Update Submitted That Met QC Criteria

October 20, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • CHUBX 2021/21

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Otosclerosis

Clinical Trials on Cone Beam CT

Subscribe